We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$23.2B
AUM Growth
+$4.57B
Cap. Flow
+$4.34B
Cap. Flow %
18.68%
Top 10 Hldgs %
24.47%
Holding
3,215
New
812
Increased
777
Reduced
812
Closed
734

Top Buys

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$286M
2
CI icon
Cigna
CI
+$183M
3
HON icon
Honeywell
HON
+$156M
4
COP icon
ConocoPhillips
COP
+$150M
5
ABT icon
Abbott
ABT
+$120M

Sector Composition

Rank Sector Weight
1 Technology 13.38%
2 Consumer Discretionary 11.26%
3 Healthcare 10.95%
4 Financials 10.85%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INST
1551
DELISTED
Instructure Holdings, Inc.
INST
$524K ﹤0.01%
+20,236
New +$521K
MCRI icon
1552
Monarch Casino & Resort
MCRI
$2.2B
$522K ﹤0.01%
7,043
-6,494
-48% -$494K
NBP
1553
NovaBridge Biosciences American Depositary Shares
NBP
$185M
$522K ﹤0.01%
150,923
+44,135
+41% +$214K
HQL
1554
abrdn Life Sciences Investors
HQL
$581M
$522K ﹤0.01%
37,446
+21,097
+129% +$302K
BKH icon
1555
Black Hills Corp
BKH
$5.42B
$521K ﹤0.01%
8,256
-2,765
-25% -$182K
MD icon
1556
Pediatrix Medical
MD
$2.18B
$519K ﹤0.01%
+34,803
New +$527K
XENE icon
1557
Xenon Pharmaceuticals
XENE
$6.06B
$517K ﹤0.01%
14,453
-61,306
-81% -$2.26M
BCAT icon
1558
BlackRock Capital Allocation Term Trust
BCAT
$1.65B
$515K ﹤0.01%
34,035
+16,828
+98% +$249K
VERV
1559
DELISTED
Verve Therapeutics
VERV
$511K ﹤0.01%
+35,443
New +$694K
PRO
1560
DELISTED
PROS Holdings
PRO
$508K ﹤0.01%
+18,538
New +$483K
CCRD
1561
DELISTED
CoreCard
CCRD
$504K ﹤0.01%
16,742
+7,136
+74% +$228K
SPRY icon
1562
ARS Pharmaceuticals
SPRY
$509M
$504K ﹤0.01%
77,369
+48,532
+168% +$373K
VNET
1563
VNET Group
VNET
$2.04B
$502K ﹤0.01%
+155,079
New +$758K
ARAY icon
1564
Accuray
ARAY
$32M
$502K ﹤0.01%
169,161
+70,574
+72% +$192K
ANNX icon
1565
Annexon
ANNX
$834M
$502K ﹤0.01%
130,377
+82,268
+171% +$453K
CWCO icon
1566
Consolidated Water Co
CWCO
$467M
$499K ﹤0.01%
30,352
+8,985
+42% +$134K
XPRO icon
1567
Expro Ltd
XPRO
$1.79B
$497K ﹤0.01%
+27,090
New +$532K
DGII icon
1568
Digi International
DGII
$2.63B
$497K ﹤0.01%
14,750
+9,212
+166% +$315K
CVGI icon
1569
Commercial Vehicle Group
CVGI
$154M
$496K ﹤0.01%
67,997
+34,975
+106% +$265K
PAVE icon
1570
Global X US Infrastructure Development ETF
PAVE
$13.9B
$496K ﹤0.01%
17,488
+98
+0.6% +$2.78K
VPU
1571
Vanguard Utilities ETF
VPU
$8.46B
$496K ﹤0.01%
3,360
+1,011
+43% +$150K
ANDE icon
1572
Andersons Inc
ANDE
$2.41B
$493K ﹤0.01%
+11,940
New +$472K
BWMN icon
1573
Bowman Consulting
BWMN
$470M
$493K ﹤0.01%
+17,163
New +$449K
SDVY icon
1574
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.6B
$488K ﹤0.01%
18,323
+9,689
+112% +$269K
BY icon
1575
Byline Bancorp
BY
$1.78B
$488K ﹤0.01%
22,552
+2
+0% +$47

Similar funds

Qube Research & Technologies (QRT)'s Q1 2023 Portfolio in Review

As of Q1 2023, Qube Research & Technologies (QRT) held 3,215 positions worth $23.2B, up 24% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.34B of net new capital in Q1 2023, opening 812 new positions and adding to 777 existing holdings. Its largest new stake was First Republic Bank: 2,786,874 shares worth $39M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $180M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q1 2023 buy was First Republic Bank: 2,786,874 shares worth $39M.
  • Qube Research & Technologies (QRT) added most to Cigna in Q1 2023, an estimated $183M increase.
  • Qube Research & Technologies (QRT)'s biggest Q1 2023 reduction was Apple, cutting an estimated $180M.
  • Qube Research & Technologies (QRT) fully exited Vertex Pharmaceuticals in Q1 2023, selling an estimated $123M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 24% of its $23.2B portfolio in Q1 2023.
  • Qube Research & Technologies (QRT) opened 812 new positions and closed 734 in Q1 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $23.2B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.